PRCT - procept-biorobotics.com PEG Multiple
Comparing the P/E ratio with growth rates demonstrates the revenue dynamics of PROCEPT BioRobotics (PRCT) from AquaBeam consumables, where the latest parameter is 0.00. Business efficiency is based on insurance reimbursements and clinic procurement. The aggressive implementation of waterjet technology in urology is displacing legacy treatment methods, confirming the company's technological breakthrough in the robotic surgery sector.
PROCEPT BioRobotics (PRCT) - metric breakdowns and financial figures
- current quotes and average value forecast:
- market capitalization statistics:
- balance sheet equity data:
- business debt structure and liquidity details:
Total Debt to Equity Ratio PROCEPT BioRobotics|PRCT - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital procept-biorobotics.com|PRCT - Company Debts|Debt to Book Value PROCEPT BioRobotics Inc|PRCT - Company Long-Term Debts|Short-Term Debt PROCEPT BioRobotics|Immediate Liquidity Ratio procept-biorobotics.com
- earnings and market ratios statistics:
PRCT - Net Profit|Company Profit Forecast PROCEPT BioRobotics|PRCT - P/E Multiple|Projected Price to Earnings Procept|PRCT - PEG Multiple|EV/EBITDA Multiple PROCEPT BioRobotics Inc|PRCT - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months PROCEPT BioRobotics|PRCT - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months procept-biorobotics.com|PRCT - Earnings growth in current year|Expected net earnings per share growth next year PROCEPT BioRobotics
Fundamental company analysis:PRCT (PROCEPT BioRobotics Corp)
For PROCEPT BioRobotics, the creator of AI-powered aquablation systems, the P/E dynamics relative to earnings growth reflect the efficiency of capitalizing on a technological breakthrough in surgery. The PEG ratio compares the market multiple with the pace of business expansion: a value below one signals that the asset is undervalued, confirming that the rapid adoption of robotics in medicine is outpacing the current share price.
Competing companies
DXCM - Price to Earnings Adjusted for Growth Rate|Penumbra Corp - Price/Earnings to Growth Multiple|PEG Multiple Novanta Photonics NOVT|HAE: Price/Earnings to Growth Multiple|inspiresleep.com - Company Value to Earnings Growth Ratio|CNMD: PEG Multiple|PLSE - Growth-Adjusted Market Cap to Net Income|INMD (InMode Corp) - PEG Multiple|Price/Earnings to Growth Multiple Picard Group (PMI)|Price/Earnings to Growth Multiple SRDX (Surmodics, Inc.)|SENS (Senseonics Holdings, Inc.) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio NeuroPace NPCE|TCMD - Price/Earnings to Growth Multiple|SANUWAVE Health, Inc. - PEG Multiple|Price to Earnings Adjusted for Growth Rate Outset Medical Corp|ELMD: PEG Multiple|Growth-Adjusted P/E Ratio LNSR|RCEL (AVITA Medical) - PEG Multiple|Profound Medical Corporation (PROF) - Growth-Adjusted Market Cap to Net Income|PEG Multiple BDMD|Price/Earnings to Growth Multiple edap-tms.com EDAP|PEG Multiple APYX (Apyx Medical Corporation)|PEG Multiple IceCure Medical Ltd. ICCM|LUNG - Price/Earnings to Growth Ratio|TELA: Price/Earnings to Growth Ratio|CTSO (cytosorbents.com) - Price/Earnings to Growth Multiple|Sensus - Growth-Adjusted Payback Ratio|ZYXI (Zynex, Inc.) - PEG Multiple|Price to Earnings Adjusted for Growth Rate electroCore Medical ECOR|Price/Earnings to Growth Ratio Vicarious Surgical Inc. (RBOT)|inspira-technologies.com (IINN) - Price to Net Income Growth Ratio|SeaStar Medical Holding Corp - Price/Earnings to Growth Multiple|PEG Multiple IRIDEX Corp IRIX|Intelligent Bio - PEG Multiple|Growth-Adjusted Market Cap to Net Income Beyond Air, Inc. XAIR|Profusa (PFSA) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio SSKN (STRATA Skin Sciences, Inc.)|Price/Earnings to Growth Ratio GlucoTrack|Price/Earnings to Growth Multiple NanoVibronix Inc. (NAOV)|PEG Multiple VERO|NUWE - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Aethlon Medical, Inc. AEMD|ASXC: Growth-Adjusted P/E Ratio|AVGR: Price/Earnings to Growth Multiple|BioSig Technologies - Company Value to Earnings Growth Ratio|Cutera, Inc. (CUTR) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio KNW (knowlabs.co)|Price/Earnings to Growth Ratio Inari Medical|NVRO: Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio ReShape Lifesciences (RSLS)|SILK - Price to Earnings Adjusted for Growth Rate
